{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:12:55Z","timestamp":1790647975850,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1086\/378092","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T15:39:19Z","timestamp":1082561959000},"page":"S251-S257","source":"Crossref","is-referenced-by-count":37,"title":["Global Measles Elimination Efforts: The Significance of Measles Elimination in the United States"],"prefix":"10.1093","volume":"189","author":[{"given":"Peter M.","family":"Strebel","sequence":"additional","affiliation":[{"name":"Global Immunization Division, National Immunization Program, Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Henao-Restrepo","sequence":"additional","affiliation":[{"name":"Expanded Programme on Immunization, Department of Vaccines and Biologicals, World Health Organization, Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hoekstra","sequence":"additional","affiliation":[{"name":"Global Measles Programme, Health Section, Programme Division, United Nations Children's Fund, New York New york"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Oliv\u00e9","sequence":"additional","affiliation":[{"name":"Expanded Programme on Immunization, Department of Vaccines and Biologicals, World Health Organization, Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[{"name":"Global Immunization Division, National Immunization Program, Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,5,1]]},"reference":[{"key":"2019041707535880700_R1","first-page":"144","article-title":"The world health report, 2001","author":"World Health Organization"},{"key":"2019041707535880700_R2","first-page":"50","article-title":"Global measles mortality reduction and regional elimination, 2000\u20132001. Part I","volume-title":"Wkly Epidemiol Rec","author":"World Health Organization","year":"2002"},{"key":"2019041707535880700_R3","article-title":"The global burden of disease 2000 project: aims, methods and data sources [discussion paper no. 36]","author":"Murray"},{"key":"2019041707535880700_R4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2105\/AJPH.90.10.1521","article-title":"Measles eradication: is it in our future?","volume":"90","author":"Orenstein","year":"2000","journal-title":"Am J Public Health"},{"key":"2019041707535880700_R5","article-title":"Executive summary [resolution no.(WHA)42.32].","author":"World Health Assembly"},{"key":"2019041707535880700_R6","article-title":"WHO vaccine preventable diseases: monitoring system\u20142001 global summary [WHO\/V&B\/01.34].","author":"Department of Vaccines and Biologicals, World Health Organization"},{"key":"2019041707535880700_R7","first-page":"986","article-title":"Progress toward interrupting indigenous measles transmission-Region of the Americas, January 1999\u2013September 2000","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"2000"},{"key":"2019041707535880700_R8","first-page":"585","article-title":"Progress toward measles elimination\u2014Southern Africa, 1996\u20131998","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"1999"},{"key":"2019041707535880700_R9","first-page":"1081","article-title":"Progress toward measles elimination-Eastern Mediterranean Region, 1980\u20131998","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"1999"},{"issue":"Supplement_1","key":"2019041707535880700_R10","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1086\/368024","article-title":"The elimination of indigenous measles transmission in England and Wales","volume":"187","author":"Ramsay","year":"2003","journal-title":"J Infect Dis"},{"key":"2019041707535880700_R11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041707535880700_R12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(00)02325-4","article-title":"Review of regional measles surveillance data in the Americas, 1996\u201399","volume":"355","author":"Hersh","year":"2000","journal-title":"Lancet"},{"key":"2019041707535880700_R13","first-page":"411","article-title":"Strategies for reducing global measles mortality: recommendations from a meeting","volume-title":"Wkly Epidemiol Rec","author":"World Health Organization","year":"2000"},{"key":"2019041707535880700_R14","article-title":"Global measles mortality reduction and regional elimination: strategic plan, 2001\u20132005 [WHO\/V&B\/01.13].","author":"World Health Organization\/United Nations Children's Fund"},{"key":"2019041707535880700_R15","article-title":"Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs [WHO\/V&B\/00.10].","author":"World Health Organization, Department of Vaccines and Biologicals","year":"2000"},{"issue":"Supplement_1","key":"2019041707535880700_R16","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1086\/377696","article-title":"Summary and conclusions: measles elimination meeting, 16\u201317 March 2000","volume":"189","author":"Katz","year":"2004","journal-title":"J Infect Dis"},{"key":"2019041707535880700_R17","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0264-410X(98)00125-X","article-title":"A model to estimate the potential economic benefits of measles eradication in the United States","volume":"16","author":"Miller","year":"1998","journal-title":"Vaccine"},{"key":"2019041707535880700_R18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.me.43.020192.002315","article-title":"The resurgence of measles in the United States, 1989\u20131990","volume":"43","author":"Atkinson","year":"1992","journal-title":"Annu Rev Med"},{"key":"2019041707535880700_R19","first-page":"1547","article-title":"The measles epidemic: the problems, barriers, and recommendations","volume-title":"JAMA","author":"National Vaccine Advisory Committee","year":"1991"},{"key":"2019041707535880700_R20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.1996.03530270064033","article-title":"Measles elimination in the Americas, evolving strategies","volume":"275","author":"De Quadros","year":"1996","journal-title":"JAMA"},{"key":"2019041707535880700_R21","first-page":"1","article-title":"Surveillance for vaccination coverage among children and adults-United States","volume-title":"MMWR Morb Mortal Wkly Rep 2000","author":"Centers for Disease Control and Prevention","year":"2000"},{"issue":"Supplement_1","key":"2019041707535880700_R22","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1086\/374720","article-title":"Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States","volume":"189","author":"Kolasa","year":"2004","journal-title":"J Infect Dis"},{"key":"2019041707535880700_R23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006454-199601000-00014","article-title":"Secondary failure rates of measles vaccine: a meta-analysis of published articles","volume":"15","author":"Anders","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2019041707535880700_R24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","article-title":"Duration of live measles vaccine-induced immunity","volume":"9","author":"Markowitz","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"2019041707535880700_R25","first-page":"3","article-title":"Southern Africa Integrated Disease Surveillance Network Feedback Bulletin","author":"World Health Organization, Southern African Sub-Regional Office","year":"2000"},{"key":"2019041707535880700_R26","first-page":"299","article-title":"Measles Outbreak-Netherlands, April 1999\u2013January 2000","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"2000"},{"key":"2019041707535880700_R27","first-page":"2","article-title":"Measles outbreak. Disease Surveillance Report of the National Disease Surveillance Centre, Ireland. July 2000","author":"EPI-INSIGHT"},{"key":"2019041707535880700_R28","first-page":"1","article-title":"Measles surveillance\u2014 United States 1991","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Centers for Disease Control and Prevention","year":"1992"},{"key":"2019041707535880700_R29","article-title":"A cost-benefit analysis of the measles-mumps-rubella (MMR) vaccine. Final Report","author":"Hatziandreau","journal-title":"Centers for Public Health Research and Evaluation, 1994"},{"key":"2019041707535880700_R30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006454-199301000-00011","article-title":"Epidemic measles in the post-vaccine era: evaluation of epidemiology, clinical presentation and complications during an urban outbreak.","volume":"12","author":"Mason","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2019041707535880700_R31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0264-410X(97)00281-8","article-title":"A benefit-cost analysis of two-dose measles immunization in Canada","volume":"16","author":"Pelletier","year":"1998","journal-title":"Vaccine"},{"key":"2019041707535880700_R32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.aje.a113511","article-title":"Measles and rubella in the United States","volume":"117","author":"Hethcote","year":"1983","journal-title":"Am J Epidemiol"},{"key":"2019041707535880700_R33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0378-1135(95)00027-8","article-title":"Towards eradication of measles virus: global progress and strategy evaluation","volume":"44","author":"Nokes","year":"1995","journal-title":"Vet Microbiol"},{"issue":"Supplement_1","key":"2019041707535880700_R34","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1086\/377713","article-title":"Population immunity to measles in the United States, 1999","volume":"189","author":"Hutchins","year":"2004","journal-title":"J Infect Dis"},{"key":"2019041707535880700_R35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/1045-1056(95)90018-7","article-title":"The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants","volume":"23","author":"Cutts","year":"1995","journal-title":"Biologicals"},{"issue":"Supplement_1","key":"2019041707535880700_R36","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1086\/368274","article-title":"Determining measles-containing vaccine demand and supply an imperative to support measles mortality reduction efforts","volume":"187","author":"Costa","year":"2003","journal-title":"J Infect Dis"},{"key":"2019041707535880700_R37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(02)09843-4","article-title":"Measles elimination in southern Africa [letter]","volume":"360","author":"Grabowsky","year":"2002","journal-title":"Lancet"},{"key":"2019041707535880700_R38","author":"PAHO field guide for measles elimination"},{"key":"2019041707535880700_R39","first-page":"99","article-title":"Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles","volume":"38","author":"Ratnam","journal-title":"J Clin Microbiol, 2000"},{"key":"2019041707535880700_R40","article-title":"Partners for measles control","author":"Grabowsky","journal-title":"Presented at the African Regional Office of World Health Organization, Task Force on Immunization Meeting Addis Ababa Ethiopia, December 2001"},{"key":"2019041707535880700_R41","article-title":"Immunize every child-GAVI Strategy for Sustainable Immunization Services","author":"Global Alliance for Vaccines and Immunization"},{"key":"2019041707535880700_R42","article-title":"Report of a meeting on research related to measles control and elimination [WHO\/V&B\/00.31]","author":"World Health Organization"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/189\/Supplement_1\/S251\/28478983\/189-supplement_1-s251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T18:52:42Z","timestamp":1555527162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/189\/Supplement_1\/S251\/823177"}},"subtitle":[],"editor":[{"given":"Samuel L.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Mark J.","family":"Papania","sequence":"additional","affiliation":[{"name":"Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta Georgia"}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":42,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2004,5,1]]},"published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1086\/378092","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,5,1]]},"published":{"date-parts":[[2004,5,1]]}}}